Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: 360iResearch | PRODUCT CODE: 1580963

Cover Image

PUBLISHER: 360iResearch | PRODUCT CODE: 1580963

Genotyping Assay Market by Offering (Instruments, Reagents & Kits, Software & Services), Technology (Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction), Sample Type, Application, End-User - Global Forecast 2025-2030

PUBLISHED:
PAGES: 195 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF, Excel & 1 Year Online Access (Single User License)
USD 3939
PDF, Excel & 1 Year Online Access (Enterprise User License)
USD 6969

Add to Cart

The Genotyping Assay Market was valued at USD 17.93 billion in 2023, expected to reach USD 20.45 billion in 2024, and is projected to grow at a CAGR of 14.42%, to USD 46.06 billion by 2030.

Genotyping assays are critical tools in genomics and biotechnology, essential for analyzing genetic variations that can reveal predispositions to diseases, personalized medicine opportunities, and agricultural innovations. The necessity of genotyping assays stems from their ability to provide detailed insights into genetic compositions, facilitating diagnostic applications, drug development, and precision agriculture. Their applications span across healthcare, where they assist in identifying susceptibilities to diseases like cancer and cardiovascular disorders, and in agriculture, promoting crop resilience and yield. Industries such as pharmaceuticals, diagnostics, nutrigenomics, and animal breeding utilize these assays extensively for varied end-use purposes.

KEY MARKET STATISTICS
Base Year [2023] USD 17.93 billion
Estimated Year [2024] USD 20.45 billion
Forecast Year [2030] USD 46.06 billion
CAGR (%) 14.42%

Key growth influencers include advancements in precision medicine, rising awareness of personalized healthcare, and innovations in agricultural biotechnology. The increasing integration of genotyping in drug development pipelines and its critical role in tailoring therapies to individual genetic profiles propels market growth. Emerging opportunities lie in expanding the genotyping assays market through enhanced next-generation sequencing technologies and integration with bioinformatics for more comprehensive data analysis, creating pathways for startups to innovate in data analytics solutions tailored for genetic data.

However, market growth is challenged by high costs associated with advanced genotyping technologies, lack of awareness in emerging markets, and ethical concerns about genetic data confidentiality. Additionally, the fast-paced technological advancements necessitate continuous investment in R&D and may lead to regulatory hurdles that need careful navigation.

For innovation, businesses can focus on developing cost-effective and portable genotyping platforms suitable for both developed and emerging markets. There's also significant potential in interdisciplinary research, combining AI and machine learning to streamline genetic data analysis, improving the efficiency and accuracy of predictions and interpretations. The nature of the genotyping assay market is highly dynamic, driven by rapid technological advancements, and offers vast opportunities for growth with a proactive stance on addressing privacy concerns and an emphasis on strategic partnerships that leverage technological synergies.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genotyping Assay Market

The Genotyping Assay Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing demand for personalized medicine
    • Increasing prevalence of genetic disorders
    • Increased research and development activities in genotyping technologies
  • Market Restraints
    • High costs associated with maintaining, and running genotyping equipment and tests
  • Market Opportunities
    • Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
    • Ongoing collaborative activities between stakeholders
  • Market Challenges
    • Complex regulatory compliances and ethical considerations associated with genotyping assay

Porter's Five Forces: A Strategic Tool for Navigating the Genotyping Assay Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genotyping Assay Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genotyping Assay Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genotyping Assay Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genotyping Assay Market

A detailed market share analysis in the Genotyping Assay Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genotyping Assay Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genotyping Assay Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genotyping Assay Market

A strategic analysis of the Genotyping Assay Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genotyping Assay Market, highlighting leading vendors and their innovative profiles. These include 3CR Bioscience Ltd., Azenta Life Sciences, Bio-Rad Laboratories, Inc., Chemagen Technologie GmbH, Danaher Corporation, Eurofins Scientific SE, Grifols, S.A., Hoffmann-La Roche Ltd., Illumina, Inc., LGC Biosearch Technologies, Mayo Clinic Laboratories, NeoGenomics Laboratories, Inc., New England Biolabs, Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC., Pacific Biosciences of California, Inc., Paragon Genomics, Inc., Promega Corporation, QIAGEN GmbH, Standard BioTools Inc., TAKARA BIO INC., Tecan Trading AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genotyping Assay Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Offering, market is studied across Instruments, Reagents & Kits, and Software & Services.
  • Based on Technology, market is studied across Microarray Analysis, Next-Generation Sequencing, Polymerase Chain Reaction, and Sanger Sequencing.
  • Based on Sample Type, market is studied across Blood Sample, Buccal Swab, Saliva Sample, and Tissue Sample.
  • Based on Application, market is studied across Agriculture, Animal Genetics, Diagnostics & Personalized Medicine, and Pharmacogenomics.
  • Based on End-User, market is studied across Academic & Research Institutes, Contract Research Organizations, Hospitals & Clinics, and Pharmaceutical & Biotech Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Product Code: MRR-4F7B2F382F32

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicine
      • 5.1.1.2. Increasing prevalence of genetic disorders
      • 5.1.1.3. Increased research and development activities in genotyping technologies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with maintaining, and running genotyping equipment and tests
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of genotyping assays with digital health platforms and electronic health records (EHRs)
      • 5.1.3.2. Ongoing collaborative activities between stakeholders
    • 5.1.4. Challenges
      • 5.1.4.1. Complex regulatory compliances and ethical considerations associated with genotyping assay
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Growing usage of instruments in research labs and hospitals for ensuring efficiency and precision
    • 5.2.2. Application: Increasing usage of genotyping assays in agriculture for enhancing agricultural yields
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Genotyping Assay Market, by Offering

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Reagents & Kits
  • 6.4. Software & Services

7. Genotyping Assay Market, by Technology

  • 7.1. Introduction
  • 7.2. Microarray Analysis
  • 7.3. Next-Generation Sequencing
  • 7.4. Polymerase Chain Reaction
  • 7.5. Sanger Sequencing

8. Genotyping Assay Market, by Sample Type

  • 8.1. Introduction
  • 8.2. Blood Sample
  • 8.3. Buccal Swab
  • 8.4. Saliva Sample
  • 8.5. Tissue Sample

9. Genotyping Assay Market, by Application

  • 9.1. Introduction
  • 9.2. Agriculture
  • 9.3. Animal Genetics
  • 9.4. Diagnostics & Personalized Medicine
  • 9.5. Pharmacogenomics

10. Genotyping Assay Market, by End-User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
  • 10.3. Contract Research Organizations
  • 10.4. Hospitals & Clinics
  • 10.5. Pharmaceutical & Biotech Companies

11. Americas Genotyping Assay Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Genotyping Assay Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Genotyping Assay Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. BD Partners with Healthians to Boost Home Diagnostic Accuracy and Expand Services in India
    • 14.3.2. Thermo Fisher Scientific Launches Pangenomix Array to Revolutionize Genomic Research and Clinical Diagnostics
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3CR Bioscience Ltd.
  • 2. Azenta Life Sciences
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Chemagen Technologie GmbH
  • 5. Danaher Corporation
  • 6. Eurofins Scientific SE
  • 7. Grifols, S.A.
  • 8. Hoffmann-La Roche Ltd.
  • 9. Illumina, Inc.
  • 10. LGC Biosearch Technologies
  • 11. Mayo Clinic Laboratories
  • 12. NeoGenomics Laboratories, Inc.
  • 13. New England Biolabs, Inc.
  • 14. Novogene Co., Ltd.
  • 15. Oxford Nanopore Technologies PLC.
  • 16. Pacific Biosciences of California, Inc.
  • 17. Paragon Genomics, Inc.
  • 18. Promega Corporation
  • 19. QIAGEN GmbH
  • 20. Standard BioTools Inc.
  • 21. TAKARA BIO INC.
  • 22. Tecan Trading AG
  • 23. Thermo Fisher Scientific Inc.
Product Code: MRR-4F7B2F382F32

LIST OF FIGURES

  • FIGURE 1. GENOTYPING ASSAY MARKET RESEARCH PROCESS
  • FIGURE 2. GENOTYPING ASSAY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENOTYPING ASSAY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENOTYPING ASSAY MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENOTYPING ASSAY MARKET DYNAMICS
  • TABLE 7. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY MICROARRAY ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BLOOD SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY BUCCAL SWAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY SALIVA SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY TISSUE SAMPLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ANIMAL GENETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY DIAGNOSTICS & PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GENOTYPING ASSAY MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES GENOTYPING ASSAY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA GENOTYPING ASSAY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY OFFERING, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM GENOTYPING ASSAY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. GENOTYPING ASSAY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. GENOTYPING ASSAY MARKET, FPNV POSITIONING MATRIX, 2023
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!